These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 50851
21. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens. Chism SE, Burton RC, Warner NL. J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560 [Abstract] [Full Text] [Related]
22. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice. Glaser M, Kirchner H, Holden HT, Herberman RB. J Natl Cancer Inst; 1976 Apr; 56(4):865-7. PubMed ID: 1255803 [Abstract] [Full Text] [Related]
23. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response. Ting CC, Kirchner H, Rodrigues D, Park JY, Herberman RB. J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388 [Abstract] [Full Text] [Related]
24. In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas. Burton RC, Warner NL. Br J Cancer; 1978 Feb; 37(2):159-70. PubMed ID: 75739 [Abstract] [Full Text] [Related]
25. Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo. Plata F, Sordat B. Int J Cancer; 1977 Feb 15; 19(2):205-11. PubMed ID: 300075 [Abstract] [Full Text] [Related]
26. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system. Plata F, Cerottini JC, Brunner KT. Eur J Immunol; 1975 Apr 15; 5(4):227-33. PubMed ID: 185057 [Abstract] [Full Text] [Related]
31. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity. Epstein LB, Knight RA. Br J Cancer; 1975 May 15; 31(5):499-512. PubMed ID: 50852 [Abstract] [Full Text] [Related]
32. Secondary specific immune response in vitro to MSV tumor cells. Senik A, Hebrero FP, Levy JP. Int J Cancer; 1975 Dec 15; 16(6):946-59. PubMed ID: 53210 [Abstract] [Full Text] [Related]
34. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens. Rao VS, Bonavida B. Cancer Res; 1976 Apr 15; 36(4):1384-91. PubMed ID: 56998 [Abstract] [Full Text] [Related]
35. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors. Fortner GW, Kripke ML. J Immunol; 1977 Apr 15; 118(4):1483-7. PubMed ID: 66296 [Abstract] [Full Text] [Related]
36. Cell-mediated antitumor immune reactions under syngeneic conditions. Leclerc JC, Senik A, Gomard E, Plata F, Levy JP. Transplant Proc; 1973 Dec 15; 5(4):1431-4. PubMed ID: 4359721 [No Abstract] [Full Text] [Related]
37. In vitro induction of tumor-specific immunity. VI: analysis of specificity of immune response by cellular competitive inhibition: limitations and advantages of the technique. Chism SE, Burton RC, Grail DL, Bell PM, Warner NL. J Immunol Methods; 1977 Dec 15; 16(3):245-62. PubMed ID: 68981 [Abstract] [Full Text] [Related]
38. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages. Jones B, Jones TC. Immunology; 1978 Feb 15; 34(2):247-55. PubMed ID: 414994 [Abstract] [Full Text] [Related]